Published in Acta Derm Venereol on January 01, 1986
Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol (1983) 1.98
Experimental production of antibodies against stratum corneum keratin polypeptides. Arch Dermatol Res (1980) 1.87
Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol (1998) 1.83
Attempt to protect rabbits against experimental syphilis by passive immunization. Br J Vener Dis (1973) 1.68
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation (1999) 1.67
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis (1985) 1.54
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Antinuclear autoantibodies in Swiss mice thymectomized at birth. Nature (1967) 1.50
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46
Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol (2000) 1.41
A truncating mutation in the laminin-332α chain highlights the role of the LG45 proteolytic domain in regulating keratinocyte adhesion and migration. Br J Dermatol (2014) 1.40
Distinctive integrin expression in the newly forming epidermis during wound healing in humans. J Invest Dermatol (1993) 1.39
[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39
A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest (1997) 1.35
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol (2001) 1.28
Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther (2002) 1.26
The role of CSA in the response to oxidative DNA damage in human cells. Oncogene (2007) 1.25
Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang (1971) 1.23
Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. J Virol (1994) 1.18
Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18
Investigation of a specific IgM antibody test in neonatal congenital syphilis. Br J Vener Dis (1970) 1.14
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Ileus and intestinal obstruction--ultrasonographic findings as a guideline to therapy. Hepatogastroenterology (1987) 1.11
Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br J Dermatol (1977) 1.11
[Immunofluorescence studies of serum autoantibodies with respect to the constituents of the epidermis of burned patients]. Experientia (1968) 1.09
Interleukin-6 in normal skin and psoriasis. Acta Derm Venereol (1992) 1.09
Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08
Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther (1998) 1.07
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis (1991) 1.06
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06
Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Br J Dermatol (1986) 1.05
Quality of life in patients with epidermolysis bullosa. Br J Dermatol (2009) 1.04
Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr (1993) 1.02
[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. Ann Dermatol Venereol (1977) 1.00
Oral photochemotherapy in the treatment of lichen planus (LP). Clinical results, histological and ultrastructural observations. Br J Dermatol (1978) 1.00
Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem (1991) 1.00
PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99
[Australia antigen, virus hepatitis and periarteritis nodosa]. Presse Med (1970) 0.99
Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol (2000) 0.99
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98
[Maternally-transmitted severe neonatal aphthosis]. Ann Dermatol Venereol (1982) 0.97
Morphological, immunological and immunocytochemical identification of lymphocytes extracted from cutaneous infiltrates. Clin Exp Immunol (1976) 0.97
Normal and psoriatic human skin grafts on "nude" mice: morphological and immunochemical studies. J Invest Dermatol (1981) 0.97
Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr (1994) 0.96
Anti-D47: a monoclonal antibody reacting with the secretory cells of human eccrine sweat glands. Br J Dermatol (1983) 0.96
Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol (2006) 0.96
CD4 antibody treatment of severe psoriasis. Lancet (1991) 0.96
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies. J Dermatol (1994) 0.96
Lichen planus and chronic graft-versus-host reaction. In situ identification of immunocompetent cell phenotypes. J Cutan Pathol (1982) 0.96
In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. Clin Exp Immunol (1982) 0.96
Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmun (1992) 0.95
[Contribution to the study of the treponeme isolated from monkeys by A. Fribourg-Blanc]. Bull World Health Organ (1969) 0.94
Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res Hum Retroviruses (1989) 0.94
Bullous dermatosis and myeloma. Monoclonal anticytoplasmic antibody activity. Arch Dermatol (1980) 0.94
Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells. Br J Dermatol (1983) 0.93
Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis. Br J Dermatol (1984) 0.93
Australia antigen and polyarteritis nodosa. Am J Dis Child (1972) 0.93
Apoptosis and efficient repair of DNA damage protect human keratinocytes against UVB. Cell Death Differ (2003) 0.93
[Significance of anti-mitochondria antibodies in liver pathology and during syphilis]. Pathol Biol (Paris) (1973) 0.93
Keratin polypeptide modifications induced by human papilloma viruses (HPV). Arch Dermatol Res (1981) 0.93
[The electron of antibodies fixed in vivo the skin level in pemphigus, bullous pemphigoid and lupus erythematosus]. Lyon Med (1972) 0.93
Carotenoid supply in breast-fed and formula-fed neonates. Eur J Pediatr (2000) 0.93
Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum Gene Ther (1998) 0.93
Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV). Clin Exp Immunol (1977) 0.93
Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. J Cutan Pathol (1989) 0.93
Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol (1991) 0.92
Sequence of changes in psoriatic epidermis. Immunocompetent cell redistribution precedes altered expression of keratinocyte differentiation markers. Acta Derm Venereol (1988) 0.92
[Leucocytoclastic vasculitis and sarcoidosis. Apropos of a case]. Ann Dermatol Venereol (1980) 0.92
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis. Cell Death Dis (2012) 0.91
New type of epidermal nevus syndrome. Dermatology (2000) 0.91
Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation (1986) 0.91
Cytokeratins in human basal and squamous cell carcinomas: biochemical, immunohistological findings and comparisons with normal epithelia. J Cutan Pathol (1982) 0.91
Involucrin expression in keratinization disorders of the skin--a preliminary study. Br J Dermatol (1987) 0.90
[SWAN mice. (Swiss antinuclear). Animal models for the study of acute, disseminated lupus erythematosus and amyloidosis. Immunopathological study]. Pathol Eur (1971) 0.90
Langerhans cells in human warts. Br J Dermatol (1986) 0.90
Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.). Arch Dermatol Res (1978) 0.90
Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man. Cell Immunol (1984) 0.90
Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage. Virology (2001) 0.89
Unique features of the mitochondrial rolling circle-plasmid mp1 from the higher plant Chenopodium album (L.). Nucleic Acids Res (1997) 0.89
Studies on T-cell subsets in atopic dermatitis: human T-cell subpopulations defined by specific monoclonal antibodies. Clin Immunol Immunopathol (1982) 0.89
Lethal autosomal recessive epidermolytic ichthyosis due to a novel donor splice-site mutation in KRT10. Br J Dermatol (2010) 0.89
In vitro infection of human epidermal Langerhans' cells with HIV-1. Immunology (1995) 0.89
A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation. Transplantation (1986) 0.89
[Erythema giratum repens in myelosarcoma]. Bull Soc Fr Dermatol Syphiligr (1970) 0.89
Primary localized gigantism and tuberous sclerosis. Arch Dermatol (1982) 0.89
Flow cytometry for separation of keratinocyte subpopulations from the viable epidermis. J Invest Dermatol (1986) 0.88
Genomic structure, promoter characterisation and mutational analysis of the S100A7 gene: exclusion of a candidate for familial psoriasis susceptibility. Hum Genet (1999) 0.88
Association of piebaldism and neurofibromatosis type 1 in a girl. Pediatr Dermatol (2002) 0.88
Identification of specific human epithelial cell integrin receptors as VLA proteins. Exp Cell Res (1990) 0.88
HLA class I antigen (heavy and light chain) expression by Langerhans cells and keratinocytes of the normal human epidermis: ultrastructural quantitation using immunogold labelling procedure. Arch Dermatol Res (1988) 0.88